Omega Therapeutics Readies $126 U.S. IPO

Rapeepat Pornsipak/iStock via Getty Images
Quick Take
Omega Therapeutics (OMGA) has filed to raise $126 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a preclinical biopharma developing genetic treatments…

Click here to view the original article.